Skip to main navigation Skip to search Skip to main content

Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study

  • Kinuko Mitani
  • , Jong Wook Lee
  • , Jun Ho Jang
  • , Yoshiaki Tomiyama
  • , Koji Miyazaki
  • , Koji Nagafuji
  • , Kensuke Usuki
  • , Nobuhiko Uoshima
  • , Tomoaki Fujisaki
  • , Hiroshi Kosugi
  • , Itaru Matsumura
  • , Ko Sasaki
  • , Masahiro Kizaki
  • , Masashi Sawa
  • , Michihiro Hidaka
  • , Naoki Kobayashi
  • , Satoshi Ichikawa
  • , Yuji Yonemura
  • , Kenta Murotani
  • , Mami Shimizu
  • Akira Matsuda, Keiya Ozawa, Shinji Nakao
  • Dokkyo Medical University
  • Samsung Medical Center, Sungkyunkwan university
  • The University of Osaka
  • Kitasato University
  • Kurume University
  • Nippon Telegraph & Telephone
  • Japanese Red Cross Kyoto Daini Hospital
  • Japanese Red Cross Matsuyama Hospital
  • Ogaki Municipal Hospital
  • Kindai University
  • Saitama Medical University
  • Anjo Kosei Hospital
  • National Hospital Organization Kumamoto Medical Center
  • Sapporo Hokuyu Hospital
  • Tohoku University
  • Kumamoto University
  • Kirin Holdings Co., Ltd.
  • Jichi Medical University
  • Kanazawa University

Research output: Contribution to journalLetterpeer-review

9 Scopus citations
Original languageEnglish
Pages (from-to)1415-1419
Number of pages5
JournalBlood advances
Volume8
Issue number6
DOIs
StatePublished - 26 Mar 2024

Cite this